Literature DB >> 23919207

Mycobacterium tuberculosis pyomyositis in an infant.

Za Malik1, M Shehab.   

Abstract

Mycobacterium tuberculosis is endemic to many parts of the world. It may have variable clinical presentations, especially in the pediatric age group. Presented here is the case of a 9-month old infant who was referred for infectious disease opinion when his thigh induration failed to improve after surgical drainage and a course of oral antibiotic therapy. Mycobacterial PCR on the operative sample fluid was found to be positive; and mycobacterial culture grew M. tuberculosis. He received 9 months of treatment with anti-TB medications, with excellent results and complete recovery. This is the first report of TB pyomyositis in an infant; and highlights the need to have a high index of suspicion for unusual organisms when conventional therapy fails to demonstrate expected results.

Entities:  

Keywords:  Abscess; Infant; Injection-site; Mycobacterium; Pyomyositis; Tuberculosis

Year:  2013        PMID: 23919207      PMCID: PMC3728880          DOI: 10.4103/2141-9248.113681

Source DB:  PubMed          Journal:  Ann Med Health Sci Res        ISSN: 2141-9248


  19 in total

1.  Pyomyositis and cutaneous abscesses due to Mycobacterium avium: an immune reconstitution manifestation in a patient with AIDS.

Authors:  Stephen D Lawn; Tihana A Bicanic; Derek C Macallan
Journal:  Clin Infect Dis       Date:  2004-02-01       Impact factor: 9.079

2.  Tuberculous pyomyositis: an unusual presentation of disseminated Mycobacterium tuberculosis infection.

Authors:  R A Bonomo; R Graham; J T Makley; C A Petersilge
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

3.  Photo quiz. Subcutaneous abscess due to Mycobacterium abscessus.

Authors:  D L Paterson
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

4.  Primary tuberculosis in the gluteal muscle of a patient with chronic renal failure. A rare presentation.

Authors:  F Ergin; H Arslan; B Bilezikçi; A M Ağildere; N Ozdemir
Journal:  Nephron       Date:  2001-12       Impact factor: 2.847

5.  Infection with Mycobacterium cheloni following injections.

Authors:  B Petrini; P Hellstrand; M Eriksson
Journal:  Scand J Infect Dis       Date:  1980

6.  Injection site abscesses caused by Mycobacterium chelonei.

Authors:  D H Gremillion; S B Mursch; C J Lerner
Journal:  Infect Control       Date:  1983 Jan-Feb

7.  Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid.

Authors:  R J Wallace; B A Brown; G O Onyi
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

8.  Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children.

Authors:  T G Connell; N Curtis; S C Ranganathan; J P Buttery
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

9.  Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

Authors:  Dick Menzies; Madhukar Pai; George Comstock
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

10.  Tuberculosis pyomyosits of the soleus muscle in a fifteen-year-old boy.

Authors:  Jamil Ahmed; James Homans
Journal:  Pediatr Infect Dis J       Date:  2002-12       Impact factor: 2.129

View more
  2 in total

1.  Answer to October 2021 Photo Quiz.

Authors:  Izabella Picinin Safe; Vanderson Souza Sampaio; Márcia Melo Damian; Vanessa Lima da Silva; Camille Albuquerque Rodrigues Chirano; Ingrid Demosthenes Wanzileu; Djane Baia-da-Silva; Jaquelane Silva de Jesus; Marcus Vinícius Guimarães Lacerda; Marcelo Cordeiro-Santos
Journal:  J Clin Microbiol       Date:  2021-09-20       Impact factor: 5.948

Review 2.  Tuberculous pyomyositis: a re-emerging entity of many faces.

Authors:  Theodora Simopoulou; Areti Varna; Zoe Dailiana; Christina Katsiari; Ioannis Alexiou; Georgios Basdekis; Konstantinos N Malizos; Lazaros I Sakkas
Journal:  Clin Rheumatol       Date:  2014-03-09       Impact factor: 3.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.